These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 12210632)

  • 1. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
    Royston P; Parmar MK
    Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
    Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
    J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regression survival model for testing the proportional hazards hypothesis.
    Quantin C; Moreau T; Asselain B; Maccario J; Lellouch J
    Biometrics; 1996 Sep; 52(3):874-85. PubMed ID: 8924576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced-rank hazard regression for modelling non-proportional hazards.
    Perperoglou A; le Cessie S; van Houwelingen HC
    Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial neural network for the joint modelling of discrete cause-specific hazards.
    Biganzoli EM; Boracchi P; Ambrogi F; Marubini E
    Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer.
    Royston P; Parmar MK; Sylvester R
    Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing proportional hazards and accelerated failure time models for survival analysis.
    Orbe J; Ferreira E; Núñez-Antón V
    Stat Med; 2002 Nov; 21(22):3493-510. PubMed ID: 12407686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A relative survival regression model using B-spline functions to model non-proportional hazards.
    Giorgi R; Abrahamowicz M; Quantin C; Bolard P; Esteve J; Gouvernet J; Faivre J
    Stat Med; 2003 Sep; 22(17):2767-84. PubMed ID: 12939785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
    Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
    J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible parametric models for relative survival, with application in coronary heart disease.
    Nelson CP; Lambert PC; Squire IB; Jones DR
    Stat Med; 2007 Dec; 26(30):5486-98. PubMed ID: 17893893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible modeling of the effects of continuous prognostic factors in relative survival.
    Mahboubi A; Abrahamowicz M; Giorgi R; Binquet C; Bonithon-Kopp C; Quantin C
    Stat Med; 2011 May; 30(12):1351-65. PubMed ID: 21432891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression analysis of interval-censored survival data with covariates using log-linear models.
    Kim DK
    Biometrics; 1997 Dec; 53(4):1274-83. PubMed ID: 9423249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interval censored survival data: a generalized linear modelling approach.
    Farrington CP
    Stat Med; 1996 Feb; 15(3):283-92. PubMed ID: 8643886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Noack F; Böhle A; Feller AC
    Oncol Rep; 2004 Sep; 12(3):609-13. PubMed ID: 15289845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint estimation of time-dependent and non-linear effects of continuous covariates on survival.
    Abrahamowicz M; MacKenzie TA
    Stat Med; 2007 Jan; 26(2):392-408. PubMed ID: 16479552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling competing risks in cancer studies.
    Klein JP
    Stat Med; 2006 Mar; 25(6):1015-34. PubMed ID: 16435339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating survival times to simulate Cox proportional hazards models.
    Bender R; Augustin T; Blettner M
    Stat Med; 2005 Jun; 24(11):1713-23. PubMed ID: 15724232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
    Lin CC; Hsu CH; Huang CY; Tsai YC; Huang KH; Cheng AL; Pu YS
    Urology; 2007 Mar; 69(3):479-84. PubMed ID: 17382149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible modeling of competing risks in survival analysis.
    Belot A; Abrahamowicz M; Remontet L; Giorgi R
    Stat Med; 2010 Oct; 29(23):2453-68. PubMed ID: 20645282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.